Bull
$4.95
シナリオ価格
$21.740
-1.298 (-5.97%)終値時点
Strive, Inc. is an asset management Bitcoin treasury company. The Company is focused on increasing Bitcoin per share to outperform Bitcoin over the long run. The Company's subsidiary, Strive Asset Management, LLC, is a SEC-registered investment adviser, which has assets under management (AUM) across approximately 13 exchange-traded funds, collective investment trusts, and a direct indexing platform. In addition, the Company owns Semler Scientific, Inc., a healthcare technology subsidiary focused on early disease detection products. Through its healthcare businesses, Semler Scientific and its wholly-owned subsidiary, CardioVanta, Inc. develop and market products and services for early detection and monitoring of chronic diseases. Semler Scientific's flagship product, QuantaFlo, provides rapid point-of-care testing to measure arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of peripheral arterial disease.
Given the current price of $21.74, the RSI at 76.558 indicates that the stock is in a strong bullish momentum. The forward P/E ratio of 3.0102 suggests that the stock is undervalued compared to its earnings potential. Additionally, the recent insider purchase of 15,900 shares by Director Pierre Rochard signals confidence in the company's future. However, the main risk is the significant year-over-year decline of 83.17%, indicating volatility and potential uncertainty in the stock's recovery.
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Strive's Bitcoin Acquisition Boosts Market Confidence

Strive Inc. Increases Bitcoin Holdings to 21,356 BTC

Fed Chairman to Speak at Jackson Hole Symposium

Bitcoin Breaks Trading Range, Market Rally Begins

Director Pierre Rochard Acquires Shares in Strive, Inc.
Strive, Inc. is an asset management Bitcoin treasury company. The Company is focused on increasing Bitcoin per share to outperform Bitcoin over the long run. The Company's subsidiary, Strive Asset Management, LLC, is a SEC-registered investment adviser, which has assets under management (AUM) across approximately 13 exchange-traded funds, collective investment trusts, and a direct indexing platform. In addition, the Company owns Semler Scientific, Inc., a healthcare technology subsidiary focused on early disease detection products. Through its healthcare businesses, Semler Scientific and its wholly-owned subsidiary, CardioVanta, Inc. develop and market products and services for early detection and monitoring of chronic diseases. Semler Scientific's flagship product, QuantaFlo, provides rapid point-of-care testing to measure arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of peripheral arterial disease. It operates in the Financials sector (SERVICES-PREPACKAGED SOFTWARE industry).
Given the current price of $21.74, the RSI at 76.558 indicates that the stock is in a strong bullish momentum. The forward P/E ratio of 3.0102 suggests that the stock is undervalued compared to its earnings potential. Additionally, the recent insider purchase of 15,900 shares by Director Pierre Rochard signals confidence in the company's future. However, the main risk is the significant year-over-year decline of 83.17%, indicating volatility and potential uncertainty in the stock's recovery.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。